MCUJF vs PYRGF
Medicure Inc. and PyroGenesis Canada Inc., side by side — 4 fiscal years reported in CAD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | MCUJF | PYRGF |
|---|---|---|
| Revenue | CAD 21.9M | CAD 19.0M |
| Net income | CAD -1.0M | CAD -32.2M |
| Gross margin | 59.7% | 42.8% |
| Net margin | −4.7% | −169.2% |
| Return on equity | — | — |
| Diluted EPS | −CAD 0.10 | −CAD 0.19 |
| Dividend / share | — | — |
| Payout ratio | — | — |
| Free cash flow | CAD 638,000 | CAD -11.5M |
| Equity | — | — |
| Net debt / equity | — | — |
| Current ratio | 1.89× | 1.06× |
| Revenue CAGR 5y | 1.7% | — |
| Profit CAGR 5y | — | — |
MCUJF bills 1.2× the revenue of PYRGF, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
4 years side by side
| Fiscal year | MCUJF | PYRGF |
|---|---|---|
| FY2022 | CAD 23.1M | CAD 19.0M |
| FY2021 | CAD 21.7M | CAD 31.1M |
| FY2020 | CAD 11.6M | CAD 17.8M |
| FY2019 | CAD 20.2M | CAD 4.8M |
Net income by year
Bottom line
| Fiscal year | MCUJF | PYRGF |
|---|---|---|
| FY2022 | CAD 1.4M | CAD -32.2M |
| FY2021 | CAD -727,000 | CAD -38.4M |
| FY2020 | CAD -6.8M | CAD 41.8M |
| FY2019 | CAD -19.8M | CAD -9.2M |